You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Harvard Business School
McKesson
McKinsey
Moodys

Last Updated: December 4, 2023

Actavis Labs Fl Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ACTAVIS LABS FL, and what generic and branded alternatives to ACTAVIS LABS FL drugs are available?

ACTAVIS LABS FL has seventy-nine approved drugs.

There are seven tentative approvals on ACTAVIS LABS FL drugs.

Summary for Actavis Labs Fl
US Patents:0
Tradenames:65
Ingredients:63
NDAs:79

Drugs and US Patents for Actavis Labs Fl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc NAPROXEN SODIUM naproxen sodium TABLET, EXTENDED RELEASE;ORAL 075416-001 Aug 27, 2002 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Actavis Labs Fl Inc FENTANYL CITRATE fentanyl citrate TABLET;SUBLINGUAL 207338-006 Nov 17, 2017 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Actavis Labs Fl Inc NITROFURANTOIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 091095-002 Jun 18, 2015 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Actavis Labs Fl Inc OMEPRAZOLE omeprazole CAPSULE, DELAYED REL PELLETS;ORAL 075347-001 May 30, 2008 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Moodys
Mallinckrodt
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.